-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$7.59M, a 68.1% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was -$69.5M, a 24.2% increase year-over-year.
- Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2022 was -$90.5M, a 12.7% decline from 2021.
- Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2021 was -$80.3M, a 9.14% increase from 2020.
- Horizon Therapeutics Public Ltd Co annual Nonoperating Income (Expense) for 2020 was -$88.4M, a 39.8% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)